828926-06-3 Usage
Uses
Used in Pharmaceutical Research:
(R)-5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBONITRILE is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
In the chemical research industry, (R)-5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBONITRILE serves as a valuable compound for studying its reactivity and potential use in creating new chemical entities with diverse applications.
Used in Drug Synthesis:
(R)-5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBONITRILE is used as a building block in the creation of new drug molecules, contributing to the development of innovative treatments for various medical conditions.
Used in Medicinal Chemistry:
(R)-5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBONITRILE is utilized in medicinal chemistry as a starting material for the design and synthesis of new therapeutic agents, potentially leading to the discovery of novel medicines with improved efficacy and safety profiles.
Used in Biological Activity Studies:
(R)-5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBONITRILE is employed in research aimed at understanding its biological activity, which may reveal new insights into its potential as a therapeutic agent or a tool for studying biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 828926-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,8,9,2 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 828926-06:
(8*8)+(7*2)+(6*8)+(5*9)+(4*2)+(3*6)+(2*0)+(1*6)=203
203 % 10 = 3
So 828926-06-3 is a valid CAS Registry Number.
828926-06-3Relevant articles and documents
Mapping the substrate scope of monoamine oxidase (MAO-N) as a synthetic tool for the enantioselective synthesis of chiral amines
Herter, Susanne,Medina, Florian,Wagschal, Simon,Benha?m, Cyril,Leipold, Friedemann,Turner, Nicholas J.
, p. 1338 - 1346 (2017/10/06)
A library of 132 racemic chiral amines (α-substituted methylbenzylamines, benzhydrylamines, 1,2,3,4-tetrahydronaphthylamines (THNs), indanylamines, allylic and homoallylic amines, propargyl amines) was screened against the most versatile monoamine oxidase (MAO-N) variants D5, D9 and D11. MAO-N D9 exhibited the highest activity for most substrates and was applied to the deracemisation of a comprehensive set of selected primary amines. In all cases, excellent enantioselectivity was achieved (e.e. >99%) with moderate to good yields (55–80%). Conditions for the deracemisation of primary amines using a MAO-N/borane system were further optimised using THN as a template addressing substrate load, nature of the enzyme preparation, buffer systems, borane sources, and organic co-solvents.
Piperazine derivatives and methods of use
-
Page/Page column 46, (2008/06/13)
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.